Additional file 1 of Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients
收藏数据链接：
官方服务：
资源简介：
Additional file 1: Supplementary Tables. Table S1. The clinicopathologic characteristics of the 14 patients received immuno-neoadjuvant therapy. Table S2. Details of the public cohorts for HRD event validation.
创建时间：
2022-05-18
